The incidence of minimal residual atherosclerotic coronary obstruction after successful intravenous thrombolytic therapy was evaluated in 799 patients with acute myocardial infarction. Minimal residual coronary obstruction (550%) was observed on selective coronary angiography performed 90 min after initiation of thrombolytic therapy in 43 patients (5.5 %). In 42 other patients (5.4%), a >50% but <100% residual stenosis noted at 90 min demonstrated further resolution of obstruction to <50% at an angiographic follow-up study 7 to 10 days later.
(1 % versus 7%; p =0.04) than did patients who had a significant (>50%) residual coronary obstl'Uction after intravenous thrombolysis.
Long-term follow-up study of patients with a minimal coronary lesion (average 1.5 ± 0.6 years) and those with significant residual stenosis (average 1.6 ± 0.7 years I demonstrated that the incidence of death (2.4% in patients with minimal stenosis versus 3.5% in those with significant stenosis) and recurrent myocardial infarction (5% each) were similar in both groups. New strategies are needed to prevent coronary rethrombosis in patients with minimal atherosclerosis after thrombolytic therapy for acute myocardial infarction.
(J flm CoilCardioI1991;17:304- 12) of infarction because of recanalization from spontaneous thrombolysis as well as attrition due to death of some patients with persistent total ,:oronary occlusion (7) (8) (9) (10) .
In many series (9, (11) (12) (13) of patients studied at necropsy or by coronary angiography, a small percent of patients who have experienced acute myocardial infarction have been found to have insignificant underlying coronary atherosclerosis. The proposed mechanisms of myocardial infarction in these patients have included prolonged severe coronary vasospasm, thrombosis with spontaneous thrombolysis and embolization with recanalization (14) (15) (16) (17) . Hypercoagulable syndromes (18) (19) (20) (21) , alteration of the hemoglobin-oxygen dissociation curve (22) , toxic i~xposure to cocaine and ethanol (22) (23) (24) , aortic dissection~Ind chest trauma (24, 25) have also been associated with the occurrence of myocardial infarction without significant fixed coronary obstruction.
Intravenous thrombolytic regimens for the treatment of myocardial infarction involving recombinant tissue-type plasminogen activator (rt-PA), combined rt-PA and urokinase or high dose intravenous urokinase have demonstrated a high rate of successful infarct-related artery recanalization (2:75%) on selective coronary angiograms obtained within 90 min of the initiation of thrombolytic therapy (26) (27) (28) vast majority of patients with successful recanalization have a persistent high grade (>50%) residual coronary stenosis of the infarct-related artery, Observations of minimal fixed residual coronary obstruction after thrombolytic therapy for acute myocardial infarction have been limited to isolated case reports (12, (29) (30) (31) (32) ,
The purpose of the present study was to evaluate the clinical characteristics and early and long-term outcome of insignificant «50%) residual coronary stenosis after intravenous thrombolytic therapy for myocardial infarction in a large prospective series of patients, This subgroup of patients with a minimal coronary lesion was then compared with those patients having a significant fixed residual stenosis (>50%) who were enrolled in the same prospective trials of intravenous thrombolysis,
Methods
Patient selection. Between December 10, 1985 and December 31, 1988, 810 patients diagnosed as having acute myocardial infarction <4 h after onset of symptoms or <6 h if severe ongoing chest pain was present were enrolled by the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) study group to receive intravenous thrombolytic therapy with rt-PA, rt-PA and urokinase in combination or high dose urokinase monotherapy, These prospective trials included the TAMI-I, TAMI-II, TAMI-III Trials and the Duke University Intravenous Urokinase Pilot Study, the details of which have been extensively outlined previously (33) (34) (35) (36) (37) . An electrocardiogram (ECG) showing ST segment elevation of 2' : 1 mm in two contiguous leads was required.
Patients were excluded for the following reasons: I) chest pain relieved by nitroglycerin or <20 min in duration; 2) age >75 years; 3) a history ofrecent stroke, surgery or trauma; 4) a predisposition to bleeding; 5) previous coronary bypass grafting; 6) previous Qwave infarction in the distribution of the infarct-related artery; or 7) cardiogenic shock, defined as a systolic blood pressure <85 mm Hg unresponsive to volume expansion. Approval by the appropriate Institutional Review Board of each site was granted before patients were enrolled.
Thrombolytic Protocol
TAMI I. In the first 178 patients enrolled, the dose of rt-PA was 60 mg during the 1st h, 20 mg/h during the 2nd and 3rd hand 10 mg for each of the last 5 h. In the remaining 208 patients, the dose during the 1st h was 1mg/kg body weight, with a maximal dose of 90 mg; the remaining amount (of a total of 150 mg) was given in equal amounts per hour in a 5 h maintenance infusion.
TAMI II. Five dose increments of combined rt-PA and urokinase were administered in TAMI-II. In groups 1 and 2, 25 mg ofrt-PA was administered with 0.5 and 1 million U of urokinase, respectively, over 1 h. In groups 3 through 5, 1 mg/kg of rt-PA (to a maximal dose of 90 mg) with 10%
given as a bolus injection was administered over 1 h in combination with 0.5, 1 and 2 million U of urokinase, respectively (35) .
TAMI III. Patients received 1.5 mg/kg of rt-PA intravenously over 4 h. The dose was 1 mg/kg over the 1st h, with 10% given as a bolus injection to a maximal 1st h dose of 90 mg. Over the next 3 h, 0.5 mg/kg was infused not to exceed a total maintenance infusion of 45 mg. Patients were randomly assigned to receive either 10,000 U of intravenous heparin or no heparin concurrently (36) .
Duke University. Patients received 3 million U of intravenous urokinase over 45 to 60 min. In 42 patients, 1.5 million U of urokinase was given as a bolus injection, followed by 1.5 million U infused over 45 to 60 min, and in 60 patients, 3 million U was administered by continuous infusion without a bolus dose (37) .
Angiography and Intervention
Indications for angioplasty. All patients underwent selective coronary angiography of the infarct-related artery and left ventriculography at 90 min after the initiation of intravenous thrombolytic therapy. Final infarct-related artery patency was determined after the fourth contrast injection according to the classification of the Thrombolysis in Myocardial Infarction (TIM!) trial (38) . Patients with persistent infarct-related artery occlusion and suitable coronary anatomy (TIMI grade 0 or 1) were offered salvage angioplasty. In the initial 386 patients enrolled (TAMI I), coronary angioplasty was performed for the following indications: I) patients with suitable coronary anatomy and a >50% residual stenosis accompanied by TIMl grade 2 or 3 flow were randomly assigned to either immediate or deferred (7 to 10 days) coronary angioplasty (34); and 2) patients with persistent infarct-related coronary occlusion (TIMI grade 0 or I flow) and suitable coronary anatomy. After the experience of TAMI I, angioplasty was not performed immediately in subsequent trials if TIMI grade 2 or 3 flow was achieved pharmacologically and was offered only to patients with persistent infarct-related artery occlusion and suitable coronary anatomy.
Antithrombotic therapy. All patients were treated with heparin (500 to 1,000 U/h) adjusted to keep the partial thromboplastin time 1.5 to 2 times above control level for 2':24 h, oral aspirin (325 mg/day) and oral diltiazem (30 to 60 mg four times per day). Patients entering the TAMI III protocol randomly received a 10,000 U bolus injection of intravenous heparin at the start of thrombolytic therapy. In the TAMI III trial, a continuous intravenous heparin infusion was not initiated until the 90 min infarct-related angiogram was performed. Additional heparin was administered if coronary angioplasty was performed in each trial. Treatment with a beta-adrenergic blocker was not begun during the study period. Duke University Intravenous Urokinase Pilot Study, 11 patients were subsequently determined not to have acute myocardial infarction. Subsequent diagnoses in these 11 patients included acute pericarditis, dissecting aortic aneurysm and normal early repolarization variant. Data on severity of residual stenosis of the infarct-related artery at 90 min were missing in 16 additional patients ( Fig. 1 ).
In the remaining 783 patien:s, initial 90 min angiography demonstrated high grade residual coronary stenosis (>50%) in 740 patients (94.5%) and no significant residual stenosis «50%) in 43 patients (5.5%). In 42 other patients (5.4%), a >50% but <100% residual stlmosis associated with TIMI grade 2 or 3 flow was noted on the 90 min angiogram, which demonstrated further resolution in severity of obstruction tõ 50% by the time of the 7 to 10 day angiogram. This reduction in severity of coronary obstruction occurred during medical therapy with heparin, aspirin, nitrates and calcium channel antagonists anc was not secondary to an interim coronary intervention. Thus, a total of 85 patients (10.9%) had insignificant atherosclerotic coronary obstruction after intravenous thrombolysis for acute myocardial infarction.
The 85 patients with minimal residual atherosclerotic Angiographic core laboratory. Residual coronary stenosis was determined by a consensus clinical reading at the investigative site and was confirmed by the blinded review of a single observer by quantitation of the residual stenosis with use of an automated edge detection computer algorithm (39) . Outlines of the cavity of the ventricle at end-systole and end-diasystole were obtained, digitized and stored in a digital radiographic computer (DPS 41OOC, ADAC Laboratories) for subsequent processing. Ventriculograms that were technically inadequate because of ventricular arrhythmic or inadequate opacification were not included in the analysis. Global ejection fraction was determined by the area-length method (40) . Regional wall motion was determined by the computer-assisted center line chord method described by Bolson et al. (41) and expressed as standard deviations (SD) per chord.
The 12 lead ECG obtained before hospital discharge was analyzed by the method of Selvester and Wagner (42) (43) (44) at the biostatistical core laboratory and a QRS score was assigned to each ECG. This score is believed to reflect the ECG magnitude of myocardial infarction in each patient. The QRS score of patients with minimal or high grade residual coronary stenosis was then compared.
Statistical methods. Case report forms were completed by the clinical research nurse coordinators and reviewed by the principal investigator at each site before submission to the Duke Data Coordinating Center. The data were verified independently by study monitors from review of the clinical records. Values for continuous variables are presented as mean ± 1 SD and for discrete variables values are presented as percents. For discrete variables, comparisons were made by chi-square analysis or Fisher's exact test and by analysis of variance for continuous variables. The prespecified hypothesis of the presence of an age and gender interaction relating to the presence of a minimal lesion was tested by logistic regression analysis.
The prespecified hypothesis of a difference in the distribution of clinical outcomes between patients with and without the presence of minimal residual coronary stenosis was tested using a composite clinical end point. This end point assigned a ranking to the worst event for each patient during the hospitalization using the following ordered levels: death, hemorrhagic stroke, nonhemorrhagic stroke, reinfarction, recurrent ischemia or heart failure and none of these events. The ranking was based on a survey of the participating investigators and has been verified by a large material sample of cardiovascular specialists. Statistical comparisons using this composite clinical end point were made by ordinal logistic regression analysis. All p values presented are two-sided. obstruction were an average age of 52.0 ± 10.7 years of age, which was significantly younger than patients having a residual high grade obstruction (56.7 ± 10 years; p = 0.001).
Male gender and cigarette smoking were found in 80% and 66% of patients with minimal stenosis and 81% and 67% of those with significant residual stenosis, respectively. Baseline clinical characteristics of both groups are illustrated in Table 1 . An interaction between age and gender was noted (Table 2 ). In younger age groups (::;49 years), the percent of patients with a minimal lesion who were female was higher, although no gender prevalence was seen for the group as a whole. No significant differences were noted in the incidence of minimal residual stenosis when the four separate prospective trials were compared (Table 3) . Angiographic characteristics (Table 4) . No significant differences were noted with respect to infarct location or infarct-related artery in the 90 min angiographic study. Patients with minimal stenosis had significantly less extensive coronary artery disease when compared with those who had a significant residual obstruction (82% no or one vessel disease versus 49%; p < 0.001). Global left ventricular ejection fraction was significantly higher (p = 0.006) at the time of immediate (90 min) angiography in patients with minimal residual coronary stenosis. Further evaluation of regional infarct and noninfarct zone function in both groups of patients revealed a significantly greater degree of hyperkinesia of the noninfarct zone in patients having minimal residual stenosis compared with patients having high grade residual stenosis after thrombolytic therapy. The degree of functional impairment noted in the infarct zone was not significantly different between groups. Hospital course (Table 5) . Patients with minimal residual coronary stenosis experienced fewer in-hospital complications than did patients having a high grade residual stenosis. This difference remains highly significant (p < 0.001) when the end points of intracranial hemorrhage and nonhemorrhagic stroke are omitted from analysis. Other clinical events not included in the composite end point that appeared to occur less frequently in patients with a minimal residual coronary stenosis than in patients with high grade coronary obstruction included angiographic coronary reocclusion (1% versus 13%), recurrent angina (5% versus 18%) and sustained hypotension (6% versus 19%). A coronary revascularization procedure, including bypass surgery and coronary angioplasty, was performed less frequently in patients with minimal versus high grade stenosis (9% versus 24% and 12% versus 69%, respectively).
The evaluation of ECG QRS scores showed similar mean values for patients with minimal (5.1 ± 3.4) and severe residual stenosis (5.1 ± 3.3). Prognosis ( Chi-square = 20.7; P < 0.001 CHF =congestive heart failure; MI = myocardial infarction; Pt = patient. Table 6 . Cause of Death in 18 Patients During the Follow-up Period stenosis versus 3.5% in those with severe stenosis) and the occurrence of nonfatal reinfarction in the long-term follow-up period (5% each) were not different between the groups (Fig. 2) . The individual causes of death during the follow-up period for patients with minimal and those with significant residual stenosis are listed in Table 6 . Only 50% of all deaths during the follow-up period were cardiovascular and 22% were related to lung carcinoma. Average follow-up duration was 541 ± 204 days (1.5 ± 0.6 years) in patients with minimal stenosis and 580 ± 259 days (1.6 ± 0.7 years) in those with significant stenosis. (1, 5, 7, (11) (12) (13) have documented the occurrence of myocardial infarction in the absence of significant fixed coronary obstruction and at times in association with a "normal" epicardial coronary tree. Although some (45) have questioned the diagnosis of myocardial infarction or the interpretation of the coronary angiogram in these instances, others (14) (15) (16) (17) have suggested coronary spasm, in-situ thrombosis or embolization with subsequent clot lysis as the cause of myocardial infarcticn in these patients. In most reported series of patients , coronary angiography has been performed 2 weeks to 1 year after occurrence of myocardial infarction and has demonstrated "insignificant" fixed obstruction in approximately 10% of patients ( Table 7) . None of these studies involved acute phase angiography or reperfusion therapy. When only the series using a definition of <50% stenosis as insignificant are included (46, 47, 49, (51) (52) (53) (54) (55) (56) (57) (58) (59) (62) (63) (64) (65) (66) (67) (68) , 8.7% of 2,364 infarction survivors had no significant fixed coronary occlusion. The reported incidence of minimal residual coronary stenosis after myocardial infarction has been greatest in the youngest age subsets of patients studied (49, 55, 58, 64, 67, 68) . A limited number of reports (30) (31) (32) (33) have documented th,~occurrence of insignificant fixed coronary obstruction after thrombolytic therapy for myocardial infarction, supporting primary coronary thrombosis as the etiology of myocardial infarction in these patients.
Findings in the thrombolytic era. This report presents a large series of patients with acute myocardial infarction treated with intravenous thrombolytic therapy and selective coronary angiography performed 90 min after initiation of thrombolytic treatment and at 7 to 10 days after infarction. This series offers the unique opportunity to evaluate the early (90 min) and late (7 to 10 day) incidence of minimal coronary stenosis in patients experiencing myocardial infarction. An important percent of patients with a significant coronary stenosis at 90 min angiography will have insignificant coronary obstruction at 1 week after further thrombus dissolution on medical therapy (34) . The incidence of minimal stenosis noted in the present series at 7 to 10 days after intravenous thrombolytic therapy (10.9%) corresponds with prior late angiographic studies ( Table 7 ) and suggests that intravenous thrombolysis may accelerate a process that would otherwise occur over a more prolonged time frame. Pathologic correlation. Recent clinicopathologic and angiographic studies (69) (70) (71) have suggested that the ease of intracoronary clot lysis may be influenced by the degree of atheromatous plaque obstruction, the presence of patent branch vessels proximal to the coronary occlusion to divert flow and the complexity of the underlying atherosclerotic lesion. Thrombus caused by superficial intimal injury may be more easily treated by fibrinolytic therapy than that secondary to deep intimal injury (72) . From the present study, we can only speculate that the arterial morphology in patients with minimal stenosis would more likely be an uncomplicated fibrofatty plaque rather than deep intimal injury or fissure. The remarkably good hospital prognosis we observed in patients with minimal stenosis (1% mortality rate) makes angiographic-morphologic correlations difficult in these patients.
Demographic factors. In this and prior studies , patients having insignificant fixed coronary obstruction after myocardial infarction have been younger in age than patients who have significant residual coronary occlusion. Although most patients with minimal stenosis are male, an interaction of gender and age was noted in the current series, with a higher percent of patients in the youngest age group being women (Table 2 ). Because women of childbearing potential were excluded from the current study, oral contraceptive use (73, 74) or spontaneous peripartum coronary dissection (75) cannot be incriminated as playing a role in coronary thrombosis or occlusion in these patients. None of the patients in the current series admitted to cocaine use in temporal association to the occurrence of myocardial infarction (76) . The incidence of antecedent angina noted in the present series (44%) is similar to that observed previously in young survivors of myocardial infarction (77) .
Although cigarette smoking has been implicated in causing coronary thrombosis in patients with insignificant fixed coronary obstruction (78, 79) , through mechanisms involving catecholamine release, coronary vasoconstriction and platelet aggregation (80, 81) , no difference in the use of cigarettes was noted between groups.
Left ventricular function. An important finding of the present study was that patients with minimal coronary stenosis have better global left ventricular function than do patients with residual high grade coronary obstruction. Although the patients with minimal stenosis may be presumed to have more rapid and more complete coronary recanalization and thus a greater degree of infarct zone myocardial preservation, no significant difference in regional infarct zone function was noted between patients with minimal or high grade stenosis. Enhanced contractility of the noninfarct zone was noted in patients with minimal stenosis and appeared to be responsible for the greater global left ventricular function in these patients (Table 4 ). This observation is probably explained by the lower incidence of multivessel coronary artery disease noted in these patients with minimal stenosis. Patients with multivessel disease may have less compensatory hyperkinesia of the noninfarct zone contributing to a lower global ejection fraction (82) .
An interesting observation of this study was the lack of difference in ECG QRS scores between patients with minimal or high grade residual coronary stenosis. This finding is consistent with the similar infarct zone regional function noted in the two groups. Thus, no difference in the extent of myocardial infarction as reflected by QRS score or regional infarct zone function could be found between groups.
Adverse clinical events. Adverse events, including death, recurrent myocardial infarction, recurrent angina and angiographic coronary reocclusion, were more frequently observed in patients having significant residual coronary ste- (Table 5) . Although high grade residual stenosis may be more likely to develop reocclusion, the more frequent presence of multivessel coronary artery disease in patients with high grade residual stenosis might also be incriminated in recurrent angina and new pulmonary edema. Coronary revascularization procedures (coronary angioplasty and bypass surgery) were utilized more frequently in patients with significant residual stenosis, again in part reflecting the higher frequency of multivessel disease.
Prognosis. Prior studies (61, 68, (83) (84) (85) (86) have suggested that prognosis after myocardial infarction is significantly influenced by the extent of underlying coronary artery disease, the degree of residual left ventricular function and patient age. Because patients with minimal residual coronary stenosis were significantly younger and had less extensive coronary artery disease and better left ventricular function, the observed lower hospital mortality rate and more benign early course observed in these patients are not surprising. However, despite improved hospital survival and a more benign hospital course, patients with minimal stenosis had a similar occurrence of death and recurrent nonfatal myocardial infarction in long-term follow-up study when compared with patients having residual high grade coronary obstruction. On the basis of these data, patients with minimal residual stenosis cannot be expected to have a particularly benign long-term prognosis as suggested by previous reports. This observation could at least in part be explained by the remarkably good long-term prognosis noted in patients having significant high grade residual coronary obstruction. A low incidence of death and recurrent myocardial infarction was noted in this group of patients. Close examination of the cause of death in both groups of patients (Table 6 ) demonstrates that only half of all deaths in both groups were due to cardiovascular causes. Thus, at an average follow-up period > 1.5 years, the incidence of cardiovascular death was approximately 1.5% in both groups. This low risk of death after myocardial infarction may in part be explained by the frequent use of coronary revascularization procedures during the initial hospitalization (87) .
Prior long-term follow-up~;tudies in patients having minimal coronary stenosis after myocardial infarction have demonstrated results similar to ours (Table 8) . At an average follow-up period of 5.6 years, the overall incidence of death, recurrent myocardial infarction and angina has been 8.5%, 9.5% and 39%, respectivel~ (12, 53, 60, 66, 80, (88) (89) (90) (91) . The overall incidence of death and myocardial infarction per year in these combined series is 1.5% and 2.7%, respectively, which is similar to the values obtained in our series.
Patients with minimal stenosis in the current series were not routinely treated with coumadin but received aspirin, a calcium antagonist and nitrate therapy. Recurrent myocardial infarction occurred in 4 of 84 patients with a minimal lesion discharged from the h05pital and was due to reocclusion of the original minimal lesion vessel in each case. Because no significant fixed stenosis had been demonstrated angiographically in these involved arteries, other pharmacologic strategies to prevent coronary rethrombosis and minimize coronary vasomotion need to be evaluated. Implications. A significant portion (10.9%) of patients receiving intravenous thrombolytic therapy for acute myocardial infarction will have insignificant residual coronary obstruction after thrombolysi~i. In 50% of these patients, a significant residual stenosis was noted on the 90 min angiogram, which demonstrated further reduction in severity to ::550% by the time of the 7 to 10 day angiogram.
This observation has implications with respect to the use of primary coronary angiopla~ty therapy for acute myocardial infarction. Because all patients with a minimal lesion had established coronary patency (TIMI grade 2 or 3 flow) on the 90 min angiogram, these data support the practice of deferred angioplasty because many patients had further reduction in the severity of re~idual stenosis after continued therapy with heparin, aspirin, nitrates and a calcium antagonist.
Patients with minimal residual stenosis after intravenous thrombolytic therapy are significantly younger and have better global left ventricular function, less extensive coro-nary artery disease, a lower hospital mortality rate and a less complicated hospital course than do patients with significant residual coronary stenosis. Despite this benign early course, these patients experienced a similar incidence of death and recurrent myocardial infarction in the long-term follow-up period as did patients having severe residual stenosis. Strategies designed to prevent late rethrombosis of infarct-related arteries with minimal fixed stenosis need to be evaluated in a long-term follow-up study.
